Giuseppe Di Pasquale
Giuseppe Di Pasquale
Tommaso Furlanello
Tommaso Furlanello
[Timing of coronary angiography in the 2020 ESC guidelines on non-ST-elevation acute coronary syndromes: when guidelines are not helpful] [0.03%]
[2020年欧洲急性非ST段抬高型冠脉综合征指南关于冠脉造影时间的推荐：当指南不给力时]
Giuseppe Di Pasquale,Gianni Casella,Alessandro Navazio et al.
Giuseppe Di Pasquale et al.
[A case of mitral valve prolapse with increased risk for sudden cardiac death in an athlete] [0.03%]
[一起有猝死危险的运动员二尖瓣脱垂病例]
Geza Halasz,Mattia Cattaneo,Matteo Badini et al.
Geza Halasz et al.
Mitral valve prolapse (MVP) is the most common valvular abnormality in athletes. The natural history of MVP is generally benign. However, MVP has been associated with an increased risk for arrhythmic sudden cardiac death (SCD). Most of thes...
[The PRIORITY study - PRedictIng long term Outcomes afteR Isolated coronary arTery bypass surgerY] [0.03%]
优先研究：孤立冠状动脉旁路术后长期结局的预测(PRIORITY研究)
Fabio Barili,Paola D&#x;Errigo,Stefano Rosato et al.
Fabio Barili et al.
The allocation of clinical and economic resources is an emerging issue in health management. A useful update necessarily depends on the evaluation of long-term outcomes of clinical and surgical resources that can permit emphasis on all amen...
[Primary aldosteronism: from diagnosis to therapy in clinical practice] [0.03%]
原发性醛固酮增多症：从诊断到治疗的临床实践
Mario Vetri,Leonarda Cassaniti,Giuseppina Maura Francese et al.
Mario Vetri et al.
Primary aldosteronism (PA) is the single most common cause of secondary hypertension and is associated with increased target organ injury. It can be can either surgically cured or treated with targeted pharmacotherapy. PA is frequently undi...
[Anticoagulant treatment in patients with non-valvular atrial fibrillation and chronic anemia: still a grey area] [0.03%]
非瓣膜性房颤合并慢性贫血患者的抗凝治疗仍存在争议
Paolo Alboni,Nicola Stucci,Anny Carole Messop
Paolo Alboni
Anemia has been associated with a higher risk of major bleeding among atrial fibrillation patients on oral anticoagulation and is therefore included in most bleeding risk scores. In contrast, much less evidence exists regarding the associat...
[Bempedoic acid: a new therapeutic opportunity for the treatment of hypercholesterolemia] [0.03%]
苯乙酸盐治疗高胆固醇血症的新机遇
Furio Colivicchi,Stefania Angela Di Fusco,Domenico Gabrielli
Furio Colivicchi
In the last decades, scientific evidence regarding the key role of cholesterol in atherosclerosis pathogenesis has led to the development of lipid-lowering treatments that can be used in addition to statins or in place of them in case of in...
[Biomarkers for the diagnosis and management of heart failure: natriuretic peptides] [0.03%]
[用于心力衰竭诊断和治疗的生物标志物:利钠肽]
Vincenzo Castiglione,Giuseppe Vergaro,Alberto Aimo et al.
Vincenzo Castiglione et al.
Heart failure (HF) is the final common pathway of many cardiovascular diseases and is associated with increased morbidity and mortality. Natural history of HF patients can be improved when early diagnosis is achieved, and a timely treatment...